Natural heterogeneity of α2-antiplasmin: functional and clinical consequences von Abdul, Shiraazkhan, Leebeek, Frank W.G., Rijken, Dingeman C., Uitte de Willige, Shirley

Volltext

Inhibition of Fibrinolysis by Coagulation Factor XIII von Rijken, Dingeman C., Uitte de Willige, Shirley

Volltext

The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays von Pieters, Marlien, Barnard, Sunelle A, Loots, Du Toit, Rijken, Dingeman C

Volltext

Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation von de Vries, Judith J., Hoppenbrouwers, Tamara, Martinez-Torres, Cristina, Majied, Rezin, Ozcan, Behiye, van Hoek, Mandy, Leebeek, Frank W. G., Rijken, Dingeman C., Koenderink, Gijsje H., de Maat, Moniek P. M.

Volltext

Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease von Uitte de Willige, Shirley, Keane, Fiona M, Bowen, David G, Malfliet, Joyce J M C, Zhang, H Emma, Maneck, Bharvi, McCaughan, Geoffrey W, Leebeek, Frank W G, Rijken, Dingeman C, Gorrell, Mark D

Volltext

Identification of fibrin clot-bound plasma proteins von Talens, Simone, Leebeek, Frank W G, Demmers, Jeroen A A, Rijken, Dingeman C

Volltext

Plasma clot lysis time and its association with cardiovascular risk factors in black Africans von de Lange, Zelda, Pieters, Marlien, Jerling, Johann C, Kruger, Annamarie, Rijken, Dingeman C

Volltext

Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasmin von Abdul, Shiraazkhan, Peeters, Miet, Brouwers, Els, Malfliet, Joyce J M C, Leebeek, Frank W G, Declerck, Paul J, Rijken, Dingeman C, Uitte de Willige, Shirley

Volltext

Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis: A Systematic Review von de Vries, Judith J., Snoek, Charlotte J.M., Rijken, Dingeman C., de Maat, Moniek P.M.

Volltext

Hypofibrinolysis is a risk factor for arterial thrombosis at young age von Guimarães, Ana H. C., De Bruijne, Emile L. E., Lisman, Ton, Dippel, Diederik W. J., Deckers, Jaap W., Poldermans, Don, Rijken, Dingeman C., Leebeek, Frank W. G.

Volltext

In black South Africans from rural and urban communities, the 4G/5G PAI-1 polymorphism influences PAI-1 activity, but not plasma clot lysis time von de Lange, Zelda, Rijken, Dingeman C, Hoekstra, Tiny, Conradie, Karin R, Jerling, Johann C, Pieters, Marlien

Volltext

Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome von Hoekstra, Jildou, Guimarães, Ana H.C., Leebeek, Frank W.G., Darwish Murad, Sarwa, Malfliet, Joyce J.M.C., Plessier, Aurelie, Hernandez-Guerra, Manuel, Langlet, Philippe, Elias, Elwyn, Trebicka, Jonel, Primignani, Massimo, Garcia-Pagan, Juan-Carlos, Valla, Dominique C., Rijken, Dingeman C., Janssen, Harry L.A.

Volltext

Comment on Ågren et al. Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes. Diabetes care 2014;37:2007-2014 von Rijken, Dingeman C, Uitte de Willige, Shirley

Volltext

Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial von Schol‐Gelok, Suzanne, Maat, Moniek P. M., Biedermann, Joseph S., Gelder, Teun, Leebeek, Frank W. G., Lijfering, Willem M., Meer, Felix J. M., Rijken, Dingeman C., Versmissen, Jorie, Kruip, Marieke J. H. A.

Volltext

Altered fibrin network structure and fibrinolysis in intensive care unit patients with COVID‐19, not entirely explaining the increased risk of thrombosis von Vries, Judith J., Visser, Chantal, Geers, Lotte, Slotman, Johan A., van Kleef, Nadine D., Maas, Coen, Bax, Hannelore I., Miedema, Jelle R., Gorp, Eric C. M., Goeijenbier, Marco, Akker, Johannes P. C., Endeman, Henrik, Rijken, Dingeman C., Kruip, Marieke J. H. A., Maat, Moniek P. M.

Volltext

The level of circulating fibroblast activation protein correlates with incorporation of alpha-2-antiplasmin into the fibrin clot von Uitte de Willige, Shirley, Malfliet, Joyce J.C.M., Abdul, Shiraazkhan, Leebeek, Frank W.G., Rijken, Dingeman C.

Volltext

On the localization of the cleavage site in human alpha‐2‐antiplasmin, involved in the generation of the non‐plasminogen binding form von Abdul, Shiraazkhan, Dekkers, Dick H. W., Ariëns, Robert A. S., Leebeek, Frank W. G., Rijken, Dingeman C., Uitte de Willige, Shirley

Volltext

Evaluation of thromboelastometry, thrombin generation and plasma clot lysis time in patients with bleeding of unknown cause: A prospective cohort study von Veen, Caroline S. B., Huisman, Elise J., Cnossen, Marjon H., Kom‐Gortat, Regina, Rijken, Dingeman C., Leebeek, Frank W. G., Maat, Moniek P. M., Kruip, Marieke J. H. A.

Volltext

How significant is the antifibrinolytic effect of lipoprotein(a) for blood clot lysis? von Rijken, Dingeman C., de Vries, Judith J., Malfliet, Joyce J.M.C., Bos, Sven, Kronenberg, Florian, Leijten, Frank P., Roeters van Lennep, Jeanine E., Uitte de Willige, Shirley, van der Zee, Leonie, Mulder, Monique T.

Volltext

Plasma levels of soluble fibroblast activation protein in arterial thrombosis; determinants and cleavage of its substrate alpha-2-antiplasmin von Uitte de Willige, Shirley, Malfliet, Joyce J.M.C, Deckers, Jaap W, Dippel, Diederik W.J, Leebeek, Frank W.G, Rijken, Dingeman C

Volltext